Loading insider details...
Latest Form 4 (Sep 4, 2026): Sale of 1,209 KYMR shares, $139.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Kymera Therapeutics, Inc. (KYMR) | Sale | 1,209 | $139.7K |
| Mar 4, 2026 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 4,125 | n/a |
| Sep 3, 2025 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 52,500 | n/a |
| Jul 30, 2025 | Relay Therapeutics, Inc. (RLAY) | Sale | 1,637 | $6.1K |
| Apr 30, 2025 | Relay Therapeutics, Inc. (RLAY) | Sale | 1,644 | $5.2K |
| Mar 31, 2025 | Relay Therapeutics, Inc. (RLAY) | Sale | 298 | $846.32 |
| Jan 30, 2025 | Relay Therapeutics, Inc. (RLAY) | Sale | 33,688 | $156.0K |
| Jan 14, 2025 | Relay Therapeutics, Inc. (RLAY) | Grant/Award | 275,000 | n/a |
| Dec 31, 2024 | Relay Therapeutics, Inc. (RLAY) | Sale | 299 | $1.3K |
| Oct 30, 2024 | Relay Therapeutics, Inc. (RLAY) | Sale | 1,632 | $9.9K |